| Entry |
|
|---|
| Name |
Fenfluramine (INN);
Ponderax (TN) |
|---|
| Formula |
C12H16F3N
|
|---|
| Exact mass |
231.1235
|
|---|
| Mol weight |
231.2574
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
| Product (DG00103): | D04148<JP/US> |
|
|---|
| Efficacy |
Appetite suppressant |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa05022 | Pathways of neurodegeneration - multiple diseases |
|
|---|
| Metabolism |
Enzyme: CYP1A2 [HSA: 1544], CYP2B6 [HSA: 1555], CYP2D6 [HSA: 1565]; CYP2C9 [HSA: 1559], CYP2C19 [HSA: 1557], CYP3A4 [HSA: 1576], CYP3A5 [HSA: 1577]
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A08 ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08A ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS
A08AA Centrally acting antiobesity products
A08AA02 Fenfluramine
D07945 Fenfluramine (INN)
N NERVOUS SYSTEM
N03 ANTIEPILEPTICS
N03A ANTIEPILEPTICS
N03AX Other antiepileptics
N03AX26 Fenfluramine
D07945 Fenfluramine (INN)
USP drug classification [BR:br08302]
Anticonvulsants
Anticonvulsants, Other
Fenfluramine
D07945 Fenfluramine (INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01705 Anoretic
DG01704 Phenethylamine anorexic
DG00103 Fenfluramine
D07945 Fenfluramine
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00103 Fenfluramine
D07945 Fenfluramine
DG02919 CYP2B6 substrate
DG00103 Fenfluramine
D07945 Fenfluramine
DG01642 CYP2C9 substrate
DG00103 Fenfluramine
D07945 Fenfluramine
DG01639 CYP2C19 substrate
DG00103 Fenfluramine
D07945 Fenfluramine
DG01644 CYP2D6 substrate
DG00103 Fenfluramine
D07945 Fenfluramine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00103 Fenfluramine
D07945 Fenfluramine
DG02925 CYP3A5 substrate
DG00103 Fenfluramine
D07945 Fenfluramine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Serotonin
HTR1D
D07945 Fenfluramine (INN)
HTR2A
D07945 Fenfluramine (INN)
HTR2C
D07945 Fenfluramine (INN)
Transporters
Solute carrier family
SLC6
SLC6A4 (HTT)
D07945 Fenfluramine (INN)
Other transporters
Auxiliary transport proteins (TC:8.A)
SIGMAR1
D07945 Fenfluramine (INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D07945
Drug groups [BR:br08330]
Gastrointestinal agent
DG01705 Anoretic
DG01704 Phenethylamine anorexic
DG00103 Fenfluramine
Metabolizing enzyme substrate
DG01892 CYP1A2 substrate
DG00103 Fenfluramine
DG02919 CYP2B6 substrate
DG00103 Fenfluramine
DG01642 CYP2C9 substrate
DG00103 Fenfluramine
DG01639 CYP2C19 substrate
DG00103 Fenfluramine
DG01644 CYP2D6 substrate
DG00103 Fenfluramine
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00103 Fenfluramine
DG02925 CYP3A5 substrate
DG00103 Fenfluramine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 16
1 C8y C 18.1300 -16.0300
2 C8x C 16.8700 -15.3300
3 C8x C 18.1300 -17.4300
4 C1b C 19.3200 -15.3300
5 C8y C 15.6100 -16.0300
6 C8x C 16.8700 -18.1300
7 C1c C 20.5800 -16.0300
8 C8x C 15.6100 -17.4300
9 C1d C 14.4200 -15.3300
10 N1b N 21.7700 -15.3300
11 C1a C 20.5800 -17.4300
12 X F 13.0900 -14.5600
13 X F 13.7900 -16.3800
14 X F 15.1900 -14.2100
15 C1b C 23.0300 -16.0300
16 C1a C 24.2200 -15.3300
BOND 16
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 2
6 4 7 1
7 5 8 2
8 5 9 1
9 7 10 1
10 7 11 1
11 9 12 1
12 9 13 1
13 9 14 1
14 10 15 1
15 15 16 1
16 6 8 1
|
|---|
